Rice Hall James & Associates, LLC Bristol Myers Squibb CO Transaction History

Rice Hall James & Associates, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	SELL	$0.13 - $76.84 $13 - $7,684	-100 Reduced 2.88%	3,370 $240,000
Q2 2022 Aug 08, 2022	SELL	$72.62 - $79.98 $7,262 - $7,998	-100 Reduced 2.8%	3,470 $267,000
Q1 2022 May 05, 2022	SELL	$61.48 - $73.72 $18,444 - $22,116	-300 Reduced 7.75%	3,570 $261,000
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $19,411 - $21,510	-338 Reduced 8.03%	3,870 $233,000
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $10,964 - $12,818	-200 Reduced 4.54%	4,208 $247,000
Q3 2019 Oct 30, 2019	BUY	$42.77 - $50.71 $188,530 - $223,529	4,408 New	4,408 $224,000
Q2 2019 Aug 01, 2019	SELL	$44.62 - $49.34 $196,684 - $217,490	-4,408 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$45.12 - $53.8 $9,024 - $10,760	-200 Reduced 4.34%	4,408 $210,000
Q3 2017 Oct 30, 2017	BUY	$55.23 - $63.74 $254,499 - $293,713	4,608	4,608 $294,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Rice Hall James & Associates, LLC with notifications on news.